DDA platform, the platform of Creative Bioarray focused on drug discovery, is dedicated to providing integrated drug discovery services to accelerate the research in the field of pharma, biotechnology companies, and academics etc. With the best screening equipment and cell models, as well as the latest innovations in drug discovery, DDA platform is capable to deliver first-class support to worldwide clients. Recently, DDA platform announced the release of its flagship — in vitro skin absorption test to support the studies in cosmetics.
Creative Bioarray is the industry leader in bioanalytical services for the cosmetic industry. More than half of the researchers on the platform hold PhD/Master's degrees and have more than 10 years of experience in cell detection. The team is equipped to provide the highly specialized analytical expertise, deep insights and innovative technologies needed to accelerate cosmetic trial success.
With strong expertise in numerous in vitro and ex vivo models and skin physiology, the DDA platform is capable of designing tailored protocols and assays. By providing personalized service through smooth communication with customers, DDA platform maximizes the quality of the work chain and responds quickly to execution and reporting. DDA platform is committed to improving the safety and effectiveness of products covering skin absorption, skin sensitization, skin microbiota, etc.
Due to regulatory changes in animal testing in the cosmetic field, in vitro models are gaining increasing attention as important tools for penetration, permeation, and skin irritation studies. Human skin equivalents are increasingly used as a supplement or more commonly as an alternative to widespread animal use. In addition, in vitro experiments also have certain advantages over in vivo studies.
In vitro experiments need to be performed with great precision and require a combination of specialized scientific skills, excellent technical knowledge and attention to detail. Drawing on the extensive scientific experience and regulatory expertise, Creative Bioarray offers OECD 428 compliant in vitro dermal absorption studies. Professional scientists will work with clients to create custom procedures using human or rat skin for analysis of finished products and cosmetic ingredients.
“DDA platform is proud of offering clients with unique, high-quality, distinctive, and tailored integrated drug discovery services.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “We are able to help our customers accelerate life science research, solve complex analytical challenges, and increase laboratory productivity with customized solutions.”
About DDA platform
As a mature division of Creative Bioarray, DDA platform definitely will be the ideal and reliable innovation partner in research endeavors. With the support of professional scientists and years of experience, We are capable to provide a knowledgeable, collaborative and flexible service to our clients so as to accelerated drug development and improved research quality for worldwide projects.
Release ID: 89064584